- Information
- AI Chat
ATI Gemfibrozil (Lopid) Med Sheet
Med Surge 1 (PNSG 2210)
Lanier Technical College
Recommended for you
Preview text
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A
Medication
STUDENT NAME _____________________________________ MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ CATEGORY CL A SS ______________________________________________________________________
ACTIVE LEARNING TEMPLATE:
PURPOSE OF MEDICATION
Expected Pharmacological Action
Complications
Contraindications/Precautions
Interactions
Medication Administration
Evaluation of Medication Effectiveness
Therapeutic Use
Nursing Interventions
Client Education
Gemfibrozil (Lopid) Fibrates
Activates peroxisome proliferator-activated receptor (PPAR). This increases production of LPL and decreased production of triglycerides. Also increases production of lipoproteins, apolipoproteins A1 & A2 which increases levels of HDL.
Available in oral form only. Taken BID 30 minutes before meals.
Statin anti-lipemic greatly increases risk for myopathy Warfarin with fibrates increases risk for bleeding
Do not take if pregnant or breastfeeding
Can cause nausea, abdominal pain, diarrhea. Increase risk of gallstones. Myopathy (pain in muscles) Can cause liver toxicity
Reduces plasma triglycerides Increased HDL cholesterol
Monitor for myopathy, GI symptoms, gall bladder disease. Measure CPK if muscle pain occurs. Monitor liver function
Triglycerides numbers are reduces and HDL cholesterol has increased
Report GI symptoms, inability to tolerate fried foods, bloating, muscle/joint pain, jaundice, and fatigue to PCP
ATI Gemfibrozil (Lopid) Med Sheet
Course: Med Surge 1 (PNSG 2210)
University: Lanier Technical College
This is a preview
Access to all documents
Get Unlimited Downloads
Improve your grades
